Annual total expenses:
$612.16M+$174.87M(+39.99%)Summary
- As of today (May 21, 2025), ANIP annual total expenses is $612.16 million, with the most recent change of +$174.87 million (+39.99%) on December 31, 2024.
- During the last 3 years, ANIP annual total expenses has risen by +$367.85 million (+150.57%).
- ANIP annual total expenses is now at all-time high.
Performance
ANIP Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$183.02M-$6.22M(-3.29%)Summary
- As of today (May 21, 2025), ANIP quarterly total expenses is $183.02 million, with the most recent change of -$6.22 million (-3.29%) on March 31, 2025.
- Over the past year, ANIP quarterly total expenses has increased by +$60.65 million (+49.56%).
- ANIP quarterly total expenses is now -3.29% below its all-time high of $189.25 million, reached on December 31, 2024.
Performance
ANIP Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ANIP Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +40.0% | +49.6% |
3 y3 years | +150.6% | +120.7% |
5 y5 years | +222.0% | +217.7% |
ANIP Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +150.6% | -3.3% | +120.7% |
5 y | 5-year | at high | +222.0% | -3.3% | +264.8% |
alltime | all time | at high | >+9999.0% | -3.3% | >+9999.0% |
ANIP Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $183.02M(-3.3%) |
Dec 2024 | $612.16M(+40.0%) | $189.25M(+12.6%) |
Sep 2024 | - | $168.03M(+26.8%) |
Jun 2024 | - | $132.51M(+8.3%) |
Mar 2024 | - | $122.38M(-0.5%) |
Dec 2023 | $437.29M(+27.8%) | $122.94M(+5.6%) |
Sep 2023 | - | $116.44M(+12.9%) |
Jun 2023 | - | $103.11M(+8.8%) |
Mar 2023 | - | $94.80M(+6.3%) |
Dec 2022 | $342.12M(+40.0%) | $89.22M(+5.2%) |
Sep 2022 | - | $84.80M(-0.4%) |
Jun 2022 | - | $85.18M(+2.7%) |
Mar 2022 | - | $82.92M(+1.8%) |
Dec 2021 | $244.31M(+9.0%) | $81.43M(+46.4%) |
Sep 2021 | - | $55.62M(-0.3%) |
Jun 2021 | - | $55.78M(+8.4%) |
Mar 2021 | - | $51.48M(-8.9%) |
Dec 2020 | $224.04M(+17.8%) | $56.48M(+12.6%) |
Sep 2020 | - | $50.18M(-16.1%) |
Jun 2020 | - | $59.78M(+3.8%) |
Mar 2020 | - | $57.62M(+9.6%) |
Dec 2019 | $190.12M(+14.4%) | $52.56M(+19.4%) |
Sep 2019 | - | $44.01M(-2.3%) |
Jun 2019 | - | $45.06M(-7.1%) |
Mar 2019 | - | $48.48M(+6.1%) |
Dec 2018 | $166.22M(+12.6%) | $45.68M(+12.5%) |
Sep 2018 | - | $40.59M(+1.5%) |
Jun 2018 | - | $40.01M(+0.1%) |
Mar 2018 | - | $39.95M(+2.4%) |
Dec 2017 | $147.61M(+44.9%) | $39.00M(+0.4%) |
Sep 2017 | - | $38.83M(+2.8%) |
Jun 2017 | - | $37.77M(+18.0%) |
Mar 2017 | - | $32.00M(+5.9%) |
Dec 2016 | $101.86M(+133.5%) | $30.22M(-1.2%) |
Sep 2016 | - | $30.60M(+17.1%) |
Jun 2016 | - | $26.14M(+75.6%) |
Mar 2016 | - | $14.89M(+26.5%) |
Dec 2015 | $43.62M(+21.3%) | $11.77M(+2.1%) |
Sep 2015 | - | $11.52M(+3.8%) |
Jun 2015 | - | $11.10M(+20.3%) |
Mar 2015 | - | $9.23M(-10.1%) |
Dec 2014 | $35.96M(+23.2%) | $10.27M(+11.7%) |
Sep 2014 | - | $9.19M(+0.9%) |
Jun 2014 | - | $9.11M(+23.0%) |
Mar 2014 | - | $7.40M(+4.7%) |
Dec 2013 | $29.18M(+14.6%) | $7.07M(+0.7%) |
Sep 2013 | - | $7.03M(-29.2%) |
Jun 2013 | - | $9.93M(+221.5%) |
Mar 2013 | - | $3.09M(-44.9%) |
Dec 2012 | $25.47M | $5.60M(+2.9%) |
Sep 2012 | - | $5.45M(-26.2%) |
Jun 2012 | - | $7.38M(+4.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $7.05M(-17.2%) |
Dec 2011 | $51.36M(+11.5%) | $8.51M(-35.6%) |
Sep 2011 | - | $13.21M(+0.5%) |
Jun 2011 | - | $13.15M(-20.3%) |
Mar 2011 | - | $16.50M(+24.0%) |
Dec 2010 | $46.08M(+16.1%) | $13.31M(+17.9%) |
Sep 2010 | - | $11.29M(+10.3%) |
Jun 2010 | - | $10.24M(-8.9%) |
Mar 2010 | - | $11.24M(-56.6%) |
Dec 2009 | $39.68M(+82.1%) | $25.91M(+427.6%) |
Sep 2009 | - | $4.91M(+3.7%) |
Jun 2009 | - | $4.74M(+14.7%) |
Mar 2009 | - | $4.13M(-24.5%) |
Dec 2008 | $21.79M(+137.6%) | $5.47M(-19.3%) |
Sep 2008 | - | $6.77M(+22.3%) |
Jun 2008 | - | $5.54M(+38.0%) |
Mar 2008 | - | $4.01M(+71.4%) |
Dec 2007 | $9.17M(-16.6%) | $2.34M(+6.9%) |
Sep 2007 | - | $2.19M(-18.9%) |
Jun 2007 | - | $2.70M(+39.2%) |
Mar 2007 | - | $1.94M(-52.8%) |
Dec 2006 | $11.00M(+15.0%) | $4.11M(+307.9%) |
Sep 2006 | - | $1.01M(-59.2%) |
Jun 2006 | - | $2.47M(-27.5%) |
Mar 2006 | - | $3.41M(+80.4%) |
Dec 2005 | $9.56M(-22.6%) | $1.89M(-7.6%) |
Sep 2005 | - | $2.04M(-25.1%) |
Jun 2005 | - | $2.73M(-5.8%) |
Mar 2005 | - | $2.90M(-32.1%) |
Dec 2004 | $12.34M(+102.0%) | $4.26M(+43.8%) |
Sep 2004 | - | $2.96M(+12.5%) |
Jun 2004 | - | $2.63M(+6.2%) |
Mar 2004 | - | $2.48M(+46.7%) |
Dec 2003 | $6.11M(-8.0%) | $1.69M(+15.4%) |
Sep 2003 | - | $1.46M(-10.0%) |
Jun 2003 | - | $1.63M(+22.5%) |
Mar 2003 | - | $1.33M(-41.0%) |
Dec 2002 | $6.64M(+46.6%) | $2.25M(+27.7%) |
Sep 2002 | - | $1.76M(+17.4%) |
Jun 2002 | - | $1.50M(+36.2%) |
Mar 2002 | - | $1.10M(-23.4%) |
Dec 2001 | $4.53M(+23.7%) | $1.44M(-1.4%) |
Sep 2001 | - | $1.46M(+60.6%) |
Jun 2001 | - | $909.80K(+26.0%) |
Mar 2001 | - | $722.00K(-25.7%) |
Dec 2000 | $3.66M(+128.4%) | $972.10K(+42.8%) |
Sep 2000 | - | $680.90K(-54.5%) |
Jun 2000 | - | $1.50M(+189.8%) |
Mar 2000 | - | $516.20K(+58.2%) |
Dec 1999 | $1.60M(-42.3%) | - |
Jun 1999 | - | $326.20K |
Dec 1998 | $2.78M | - |
FAQ
- What is ANI Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual total expenses year-on-year change?
- What is ANI Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly total expenses year-on-year change?
What is ANI Pharmaceuticals annual total expenses?
The current annual total expenses of ANIP is $612.16M
What is the all time high annual total expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total expenses is $612.16M
What is ANI Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ANIP annual total expenses has changed by +$174.87M (+39.99%)
What is ANI Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ANIP is $183.02M
What is the all time high quarterly total expenses for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total expenses is $189.25M
What is ANI Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ANIP quarterly total expenses has changed by +$60.65M (+49.56%)